Matching slides 10,471
Current window 6,151-6,180
Pages 350
Rows per page 30
Slide type: Tractionclear collectionreset all

Slide type

6,151-6,180 of 10,471

filter-aware
17
This is a validation/credibility slide.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
21
The slide serves as a visual proof point of market expansion and brand presence.Gogoro | Investor Presentation Deck | 30 slides · Gogoro
Pitch deck Investor relations 1 hit
14
The chart shows cumulative growth from 2010 to 2022. The table highlights the specific opportunity in post-1980 vehicles.Hagerty | Investor Presentation Deck | 24 slides · Hagerty
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The slide uses a mix of lifestyle imagery and data points to demonstrate brand strength.Hagerty | Investor Presentation Deck | 24 slides · Hagerty
Pitch deck Investor relations 1 hit
20
Includes a footnote indicating data is as of November 2022.Hagerty | Investor Presentation Deck | 24 slides · Hagerty
Pitch deck Investor relations 1 hit
24
The chart uses a stacked area format to visualize revenue diversification and growth trajectory from 2018 to 2025E.Hagerty | Investor Presentation Deck | 24 slides · Hagerty
Pitch deck Investor relations Beat · Financials1 hit
13
The slide uses a timeline-like structure to show regulatory milestones by country.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
14
Hyperfine | Investor Presentation Deck | 22 slidesHyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
16
The chart shows revenue in millions. 2023 is a projected range.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
17
The chart is a waterfall-style progression showing margin improvement.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
18
The slide uses a bar chart to visualize the reduction in cash burn and a callout box for the current cash position.Hyperfine | Investor Presentation Deck | 22 slides · Hyperfine
Pitch deck Investor relations 1 hit
04
IBEX | Investor Presentation Deck | 18 slidesIBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Early Struggles1 hit
05
IBEX | Investor Presentation Deck | 18 slidesIBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Early Struggles1 hit
06
The slide highlights growth in profitability and cash flow despite a slight decrease in revenue.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Early Struggles1 hit
12
The chart shows revenue growth for cohorts starting in FY19-FY23, with Year 2 and Year 3 data for recent cohorts being estimates.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · Rising Success1 hit
13
The chart uses a trend arrow to emphasize the CAGR.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough1 hit
14
The bar chart shows a clear trend of decreasing US revenue and increasing Offshore/Nearshore revenue over 2021-2023.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough1 hit
15
The slide uses donut charts to illustrate client concentration metrics for Q1 FY24.IBEX | Investor Presentation Deck | 18 slides · ibex
Pitch deck Investor relations Beat · The Breakthrough1 hit
09
The slide uses a timeline framework to demonstrate historical traction and partnership growth.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Solution1 hit
17
Slide compares two generations of therapy; includes clinical metrics like cORR and mDOR.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
23
Includes waterfall plot for BOR and spider plot for response over time. Data cut-off Sep 30, 2023.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
30
Includes waterfall plot and spider plot (longitudinal response). Data cut-off Sep 30, 2023.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
31
Includes p-values for statistical significance across four distinct clinical metrics.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
33
The slide uses a two-row layout to contrast GEN1 and GEN2 therapies, each with a 'Next Step' callout.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations Beat · Traction1 hit
52
Includes study design timeline, histology details, and comparative tumor volume charts (group averages vs individual mice).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
56
The chart uses a broken x-axis between -29 and 0. The legend indicates four distinct treatment groups.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
57
The slide uses a log-linear plot to demonstrate drug clearance over time.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
71
Includes waterfall plot and spider plot for RECIST 1.1 response metrics.Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
72
Includes waterfall plot and spider plot (change in tumor size over time).Immatics | Investor Presentation Deck | 75 slides · Immatics
Pitch deck Investor relations 1 hit
18
The chart demonstrates the mechanism of action: rapid cell expansion followed by clearance within 30 days, correlating with disease marker reduction.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Pitch deck Investor relations Beat · Traction1 hit